Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    16549646 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Patients With Intermittent Claudication Injected With ALDH Bright Cells
Conditions: Peripheral Artery Disease;   Intermittent Claudication
Interventions: Biological: ALD-301;   Biological: Placebo (vehicle)
2 Recruiting Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Danshen Gegen Capsule;   Drug: Placebo
3 Not yet recruiting The Chocolate Touch Study
Conditions: Intermittent Claudication;   Ischemia
Interventions: Device: Chocolate Touch;   Device: Lutonix Drug Coated Balloon
4 Recruiting Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
Condition: Peripheral Arterial Disease
Interventions: Drug: Clopidogrel;   Drug: Acetylsalicylic acid (ASA)
5 Completed Intensive Rehabilitation in Peripheral Arterial Disease With Claudication: Effects of a Treadmill Training With Active Recovery
Conditions: Peripheral Arterial Disease;   Claudication
Interventions: Procedure: experimental rehabilitation program;   Procedure: conventional rehabilitation program

Study has passed its completion date and status has not been verified in more than two years.